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Human papillomavirus (HPV) is known as a strictly epitheliotropic pathogen. Our results raised the possibility that HPV 16 is present in neural
cells and in the vascular endothelium. By in situ hybridization, we have detected HPV 16 E6 ORF sequence in small blood vessels and peripheral
nerves adjacent to oral and cervical cancers. The same structures have clearly shown immunohistochemical reactivity for the E6 oncoprotein.
These results were verified by PCR applied to E6 and L1 ORFs following microscopic laser dissection of the immunohistochemically positive
nerves and vessels.
These observations suggest that HPV 16 DNA and protein are present in neurons and endothelial cells in the vicinity of HPV-associated
tumors. The HPV 16 genome presumably exists in a non-replicating form in the neurons and constitutively produces high levels of E6 and E7
proteins with an unknown neuropathological outcome.
© 2005 Elsevier Inc. All rights reserved.Keywords: Papillomavirus; HPV; Endothelium; Neuron; Cervical cancer; Oral cancerIntroduction
Human papillomavirus 16, the most potent oncogenic
member of the Papillomavirus family, is regarded as a major
independent tumorigenic risk factor in human epithelial malig-
nancies, especially in cervical cancers (zur Hausen, 2002) and it
may also contribute to formation of head and neck squamous cell
carcinomas (HNSCC-s) (Gillison, 2004). An etiopathogenic role
in the development of various other human tumors, e.g.
esophageal carcinomas (de Villiers et al., 2004) and non-small
cell lung cancers (NSCLCs), has been attributed to HPVs (Chiou
et al., 2003; Zafer et al., 2004). Furthermore, the presence of⁎ Corresponding author. Fax: +1 36 1 317 1074.
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doi:10.1016/j.virol.2005.12.043HPV 16 has been reported in colorectal carcinomas (CRCCs)
(Audeau et al., 2002; Cheng et al., 1995) and breast cancer as
well (Damin et al., 2004).
DNA replication of HPVs is strictly synchronized with the
life cycle of host cells which, according to our present state of
knowledge, are of epithelial origin (Desaintes and Demeret,
1996; Sen et al., 2004). Expression of the early genes E6/E7
requires a unique constellation of AP-1, Sp1, and NFI trans-
cription factors characteristic to epithelial cells (Apt et al., 1996).
Viral DNA replication is coupled to replication of basal cells in
the cervical epithelium, and late viral protein production is
synchronized with maturation of keratinocytes (del Mar Pena
and Laimins, 2001; Sailaja et al., 1999; Schwartz, 2000).
Early viral proteins E6 and E7 are key players in malignant
transformation, as they inactivate pRb and p53 tumor suppres-
sors and interact with other important factors of growth control.
Concomitant with their integration, HPVs often lose parts of the
viral genome including E1 and E2 regulator genes. Integration of
Fig. 1. (A) HPV 16 E6 (clone C1P5) immunoreaction in a peripheral nerve in the
peritumoral area of a cervical squamous cell carcinoma. Immunohistochemistry,
DAB. Magnification ×200. (B) The same region in the negative control slide
processed without primary antibody. Magnification, ×200.
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constitutive deregulated production of these oncoproteins,
which drives the infected cell into a state of increased
proliferation, thereby leading to malignant transformation (zur
Hausen, 2002).
While trying to unveil the precise pathogenic role of high-
risk HPVs in HNSCCs and cervical carcinomas, we observed
the presence of HPV 16 E6 in several non-epithelial cell types
like neurons and endothelial cells. Supporting that, multiple
parallel methods provided further evidences consistent with our
previous results.
Results
We have screened 50 HPV 16-associated samples (15
cervical and 35 head and neck cancers) for the presence of
HPV 16 E6 protein by immunohistochemistry. In eight of 50Fig. 3. Simultaneous identification of HPV 16 E6 and S100 by double immunofluores
16 E6 (clone C1P5); (B) S100 (rabbit polyclonal); (C and D) Merged images. Blue nu
panel A) as well as in neurites (arrow in panels A, B, and C). Within the same sam
arrowheads in panel D, respectively), ruling out non-specific cross reaction of the a
Fig. 2. (A) Detection of HPV 16 E6 oncoprotein (green) in a sublingual squamous ce
cytoplasm (arrowhead) of tumor cells. Fluorescent immunohistochemistry (clone C1
Presence of HPV 16 E6 oncoprotein (green) in the endothelial cells of a blood vessel
endothelial cells (arrowheads). Autofluorescent structures in the lumen are red bloo
HPV 16 E6 immunopositivity (green) in the endothelial cells of a blood vessel adjac
Arrowheads show cytoplasmic immunostaining of the cells. Fluorescent immunohist
(D) The same area viewed by phase contrast microscopy. Arrowheads show the samcases (two cervical cancers and six HNSCCs), peripheral nerves
in the peritumoral area showed strong immunohistochemical
reaction using a monoclonal antibody against HPV 16 E6
oncoprotein (Fig. 1). In addition to that, peritumoral blood
vessels also showed immunopositivity in six of these samples
(two cervical and four HNSCC specimens) (Fig. 2). Vascular
immunopositivity for HPV E6 oncoprotein was localized to
endothelial cells and was further confirmed by confocal laser
scanning microscopy (Fig. 2C). In peripheral nerves, E6 immu-
nostaining was most evident in the neurites and was sporadically
presented in the nuclei of Schwann cells. Interestingly, while
some nerves reacted unequivocally, others remained unstained
even in a positive surrounding (Fig. 3). In order to validate these
unexpected results, a biotin-independent amplification was also
carried out using EnVision system, that showed identical
staining pattern of nerves and blood vessels.
To confirm our results, immunhistochemistry was performed
using a monoclonal antibody against HPV 16 E7 protein. In
harmony with above immunostainings, blood vessels and nerves
in the peritumoral area reacted with E7 antibody as well. While
E6 immunoreaction was observed both in the nucleus and in the
cytoplasm of the affected cells, E7 predominantly showed
nuclear localization (Fig. 4). On the same samples, immunohis-
tochemistry for HPV major capsid protein L1 was performed,
but in spite of the presence of E6 and E7, no staining was found
in non-epithelial cells.
Examination of these tissue samples with indirect in situ
hybridization confirmed the findings above. Probes directed
against viral sequences hybridized to areas of endothelial cells
and peripheral nerves. In the peritumoral area of HNSCC, in an
indirect fluorescent assay using commercial probes, very few of
the endothelial cells and nerves reacted. However, these signals
were comparable in intensity with those seen in squamous cells
and tumor cells (Fig. 5). Alkaline phosphatase-visualized ISH
with fluorescein-labeled probes on nerves in a cervical
specimen was even more pronounced (Fig. 6).
With a laser microdissector, we carefully excised the immu-
nohistochemically E6-positive blood vessels and nerves at a
distance of 2–5 mm from the tumor-infiltrated part of the spe-
cimen. Following DNA extraction, PCRs were performed using
various HPV-specific primer pairs. Nested PCR for HPV 16 E6
ORF yielded positive results on samples deriving from both
nerves and vascular tissues (Fig. 7). The sequence of the ampli-
fied product showed exact matching with the gene coding
Human papillomavirus type 16 E6 protein (GenBank accessioncence in peripheral nerves adjacent to an oral squamous cell carcinoma. (A) HPV
clear staining: DAPI. HPV 16 E6 appears in Schwann cell nuclei (arrowheads in
ple, both HPV 16 E6 positive and negative nerves could be found (arrow and
ntibody with neural structures. Magnification, ×400.
ll carcinoma. Immunofluorescent signals can be seen in the nucleus (arrow) and
P5), streptavidin-FITC. Nuclear counterstain: DAPI. Magnification, ×200. (B)
adjacent to an oral squamous cell carcinoma. Immunopositivity was localized to
d cells. Fluorescent immunohistochemistry as above. Magnification, ×400. (C)
ent to a cervical carcinoma is confirmed by confocal laser scanning microscopy.
ochemistry as above. Nuclear staining: propidium iodide. Magnification, ×1000.
e cells as above.
Fig. 2.
Fig. 3
291T. Füle et al. / Virology 348 (2006) 289–296no. AF404702). PCR results with the primers designed for the
region coding L1 capsid protein was similarly positive, indi-
cating the possible presence of the complete viral genome in
these cells.
Discussion
Recurrent findings called our attention to the possible pre-
sence of HPV 16 viral sequences and protein products in non-
epithelial cells. This seems to contradict the current dogma that
human papillomaviruses are epitheliotropic agents. The recog-
nition that HPVs can persist in a wider range of host cells may
open novel perspectives in the epidemiology and pathophysi-
ology of these viruses, notwithstanding that the exact mecha-
nism underlying this newly revealed phenomenon is yet unclear.
Considering the extreme sensitivity of nested PCR, HPV
DNA detected in non-epithelial tissues could have derived from
even a very small number of contaminating tumor cells. How-
ever, the lack of cytokeratin immunostaining in areas parallel to
the microdissected target fields ruled out the presence of tumor
cells in the dissected tissue fragments. On the other hand, the
possibility of false positives can be excluded, given the con-
sistent negativity of all technical and biological negative controls
included in the study.
We hypothesize that the appearance of HPV E6 protein, and
perhaps of the complete viral genome in the endothelium is in
connection with the antigen-presenting function of endothelia
(Risau et al., 1990; Rothermel et al., 2004; Savinov et al., 2003).
Endothelial cells possess a phagocytic activity, thus the source
of E6 protein and viral sequences may be the infected
environment of the vessels, particularly the disintegrating
tumor cells. Macrophages around and inside of tumors actively
engulf viral nucleic acid and proteins, resulting in their
positivity with ISH and IHC. Since endothelial cells have the
same potential, these molecules can simply be absorbed by the
endothelium from the surrounding HPV-contaminated tissue.
Presumably neither E6 nor the detected viral DNA is
synthesized by the endothelial cells themselves..
Fig. 4.
292 T. Füle et al. / Virology 348 (2006) 289–296On the other hand, we suppose that HPV E6 protein and viral
DNA have a different origin in neural structures, as they might
be synthesized autonomously by neurons and Schwann cells.Fig. 5An intensive local E6 production may account for the massive
IHC reaction. Transcription factors such as AP-1, Sp1, and NFI
sufficient for early viral protein expression are active indeed in.
293T. Füle et al. / Virology 348 (2006) 289–296neurons and glial cells (Baumeister et al., 1999; Behrens et al.,
2000; Fleegal and Sumners, 2003; Pearson et al., 2003; Ryu et
al., 2003; Wegner, 2000).
It has been reported that the localization of HPV E6 protein is
mainly nuclear in tumor cells (Tao et al., 2003). However,
oncoproteins of high risk HPVs can be distributed throughout
the cell, which allows them to interact with a wider range of
cellular proteins (Guccione et al., 2002). Indeed, E6 immuno-
reaction (Fig. 2A) and E7 staining (Figs. 4A and B) appeared in
both nuclear and cytoplasmic localizations in the tumor cells. As
for nonmalignant structures, HPV E6 was seen in Schwann cell
nuclei and in neurites as well (Fig. 3), whereas E7 immunostain-
ing was clearly restricted to the Schwann cell nuclei. While E6
has a number of cytoplasmic partners, E7 generally tends to
interact with nuclear factors, which may account for the
difference in their distribution in peripheral nerves.
It is well-known that members of Alphaherpesvirinae, an
unrelated DNAvirus subfamily with representatives like Human
herpesvirus 1 (Herpes simplex virus 1—HSV1), Human her-
pesvirus 2 (Herpes simplex virus 2—HSV2), or Human her-
pesvirus 3 (Varicella-zoster virus—VZV), use the peripheral
nerve ganglia as reservoirs (Connor and Gibson, 1988). These
viruses assume a latent form in ganglia from where they can
occasionally reinfect the corresponding dermatome or can
disperse to cause generalized infection in immunocompromised
patients. However, Alphaherpesviruses clearly differ fromHPVs
in both their life cycle and transcriptional strategy; an analogy
between the two groups is therefore weakly founded.
Papillomavirus replication is strictly tied to the doubling of
host epithelial cell's DNA, and virion formation is synchronized
with epithelial maturation. Conversely, neurons in adults are
arrested in G0 phase; i.e. they are unable to divide. The lack of
an active DNA replication machinery in these cells may present
severe limitations for HPV virion production.
The expression of late viral proteins in neurons raises further
questions. Our observations indicate that although L1 late
capsid gene is present, it is silent in nerves, notwithstanding that
they express E6 and E7 early genes. These facts make us
assume that in spite of E6 and E7 production in the affected
neurons, neither HPV replication nor virion formation takes
place in them.
Hence, neurons seem to represent a dead end for HPV as, in
principle, they are unable to support complete virion assembly.Fig. 5. Detection of HPV 16 DNA sequence by indirect fluorescent in situ hybridiz
show the presence of the viral sequences; blue nuclear staining: DAPI. (A) Head and n
and also a diffuse cytoplasmic signal (arrowhead) may appear. Magnification, ×1000.
integration of the viral genome. Magnification, ×1000. (C) Peripheral nerve adjacent t
occasionally positive. Magnification, ×200.
Fig. 4. HPV 16 E7 (TVG701Y) immunohistochemistry on oral squamous cell carci
associated tumor shown in panel B. Immunostaining is localized into the nuclei (e.g
peripheral nuclear staining (arrowhead) and cytoplasmic staining (arrow) both appear
nerve in the vicinity of the tumor shown in panel B. Some Schwann cell nuclei are
difference from E6 immunoreaction (Figs. 1A, 3A): E7 immunostaining is clearly
vicinity of the tumor shown in panel B. Two nerves, one E7-positive (black arrowhe
positive endothelium (arrow) are shown. (F) Nerve and blood vessel adjacent to
Magnifications, ×100 (A), ×200 (E), ×400 (B, C, D, F).These cells therefore have no relevance as potential sources of
viral recurrence in the human organism. The consequences of
early viral protein production going on in a mature neuron for
years or even decades are unknown, but these proteins may
possibly impede important physiological functions. The
question whether other early proteins, especially E1 and E2
regulatory gene products are also expressed, at this point remains
unanswered.We expect that further analysis of this phenomenon
will reveal the exact pathological significance of HPV 16
presence in these cells.
No data in the literature indicate that HPV could replicate in
neuronal cells, or such cells could transcribe papillomavirus in
culture. Recently, two independent groups published data that
reinforce our speculations. Both groups reported the presence of
HPV 16 in retinoblastoma, a malignant tumor of diencephalic
origin (Montoya-Fuentes et al., 2003; Palazzi et al., 2003). This
is, however, a strongly preliminary finding which may be due to
contamination of specimens by HPV found in the conjunctiva.
Still, if proven to be biologically relevant, these data may
provide further evidence for the notion that neural structures can
harbor HPVs.
Materials and methods
Fifty formalin-fixed and paraffin-embedded tissue samples
were examined from tumor specimens (15 cervical and 35 head
and neck cancers) obtained from the 1st Department of
Obstetrics and Gynecology and the Department of Oral Surgery
and Dentistry, Semmelweis University, Budapest. All of these
squamous cell cancers have been histologically evaluated by
specialists in gynecological and oral pathology, and diagnosed
as HPV 16 associated tumors by PCR to HPV 16 E6 open
reading frame (ORF) and immunhistochemistry for E6 protein.
The experiments were carried out with the consent of the
regional ethical committee.
In situ hybridization methods
In one series of experiments, in situ hybridization was
accomplished with fluorescein-labeled fragments as probes
amplified by PCR from cloned HPV 16 genome. The sequence
of this probe corresponds to a 306 bp fragment (35–341) of HPV
16 genome (GenBank accession no. NC_001526). Fasttag FLation using biotinylated HPV 16 DNA probe (DakoCytomation). Green signal
eck squamous cell carcinoma. In the tumor cells, a diffuse nuclear signal (arrow
(B) Cervical carcinoma. A single, dot-like signal in the nucleus (arrow) indicate
o a cervical carcinoma. Using this method, Schwann cell nuclei (arrow) are only
nomas and peritumoral areas. (A) Dysplastic epithelium adjacent to a HPV 16-
. arrowheads). (B) HPV 16-associated squamous cell carcinoma. Characteristic
in the tumor cells. (C) A HPV-free tumor lacks immunostaining. (D) A peripheral
E7-immunopositive (arrowheads), while others are negative (arrows). Note the
restricted to the Schwann cell nuclei. (E) Various peritumoral structures in the
ad) and one E7-negative (white arrowhead), as well as a blood vessel with E7-
the HPV-free tumor shown in panel C. Note the lack of immunostaining.s
)
s
Fig. 6. (A) Detection of HPV 16 E6 ORF DNA sequence in peripheral nerves
adjacent to a cervical carcinoma by in situ hybridization using a fluorescein-
labeled probe (non commercial). After non-fluorescent development, staining
appears in Schwann cell nuclei (arrows) as well as in cytoplasmic areas. (B) The
same region in the technical negative control slide, processed without probe.
Magnification, ×400.
Fig. 7. HPV E6 ORF-specific nested PCR on DNAs isolated from
microdissected tissues of E6 immunopositive HNSCC biopsies as templates.
The products were separated on a 2% agarose gel, and stained with ethidium
bromide. Lane 1: DNA molecular weight marker; lane 2: striated muscle
adjacent to the tumor (control sample); lane 3: tumor cells; lane 4: blood vessels;
lanes 5, 6: peripheral nerves; lanes 7, 8: negative control of first (no DNA) and
second round of nested PCR; lane 9: cloned plasmid containing HPV 16 DNA
(positive control). Arrow on the left shows the band of 124 basepair length HPV
16-specific DNA fragments. The bands of PCR fragments can be seen at the
same size in lanes 3, 4, 5, and 6.
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label PCR fragments according to themanufacturer's guidelines.
Specificity of the labeled probe was verified by dot blot and
Southern blot techniques to exclude contamination and cross-
hybridization with other types of HPV. Reactions involving this
probe were visualized by a non-fluorescent method.
In the other series of experiments, we used HPV type 16
biotinylated DNA probe from DakoCytomation (Glostrup,
Denmark). This probe (code: Y1407) hybridizes to regions of
the E1, E2, E4, E5, E6, and E7 ORFs, as well as the upstream
regulatory region (URR) of human papillomavirus (HPV) type
16. In these series, hybridization was detected by indirect
fluorescence assay.
For non-fluorescent ISH, 3–4 μm thick paraffin-embedded
tissue sections were deparaffinized and rehydrated. Samples
were treated with Pretreatment Solution (Qbiogene Inc., Carl-
sbad, CA, USA), and proteins were digested with Proteinase-K
(0.1 μg/ml) for 10 min at 45 °C. After pre-hybridization treat-
ment (25% formamide, 4× SSC (saline-sodium citrate), 1 mM
EDTA, 50 mM dihydrogen sodium phosphate/disodium hydro-
genphosphate, 1 mg/ml salmon sperm DNA, 5× Denhardt solu-
tion in water) for 30 min at 37 °C, sections were denatured at 95
°C for 6 min. At the same time, fluorescein-labeled probe was
denatured in hybridization buffer (Amersham Biosciences UK
Ltd., Buckinghamshire, England). Slides were put on ice and the
pre-hybridization mixture was quickly replaced with 400 ng/ml
fluorescein-labeled DNA in hybridization buffer. Hybridizationwas carried out overnight at 37 °C. After washing in 2× SSC/
0.1% SDS at 45 °C, slides were treated with 20% acetic acid for
20 s to block endogenous alkaline phosphatase (AP) activity.
Fluorescein was detected with AP-conjugated anti-fluorescein
Fab fragments (Boehringer-Mannheim, Germany) using NBT
(nitro blue tetrazolium) and BCIP (5-bromo-4-chloro-3-indolyl
phosphate) as chromogenic substrates.
For indirect fluorescent ISH, deparaffination, pretreatment,
and digesting of sections were performed as described above.
Following digestion, sections were immersed in 1% H2O2 in
methanol for 20 min, and rinsed in deionized water. Hybridiza-
tion was performed according to the manufacturer's guideline.
After stringent washing in 0.2× SSC/0.1% SDS at 58 °C for 20
min, detection of hybridized probe was performed using
biotinylated anti-mouse IgG antibody and VectaStain ABC Kit
(Vector). Subsequently, we used biotinyl-tyramide at a dilution
of 1:125 for extra amplification. Finally, streptavidin-FITC
(DakoCytomation) was applied onto the slides, and nuclei were
counterstained with propidium-iodide or DAPI (Qbiogene Inc.)
Technical negative control samples were processed without
specific probes. In every series of hybridization, HPV DNA-free
HNSCC samples and pancreas samples were included as
biological negative controls.
Immunohistochemistry
After deparaffinization and rehydration, tissue sections were
subjected to an antigen retrieval procedure using microwave,
immersing the slides in boiling citrate buffer (pH 4) for 18 min,
then proteins were mildly digested with trypsin (0.01% w/v) for
5 min. Endogenous peroxidase was inactivated and non-specific
protein binding was blocked. Primary antibodies for papillo-
mavirus (HPV), clone K1H8 (DakoCytomation), human
papillomavirus 16, 18 E6, clone C1P5 (Chemicon International
Inc., Temecula, CA, USA), and human papillomavirus 16 E7,
clone TVG701Y (Lab Vision Co., Fremont, CA, USA) were
diluted 100-fold. Sections were incubated with primary anti-
bodies for 90 min at 37 °C. Technical negative control samples
were processed without specific monoclonal antibody. In every
series of IHC, HPV-free HNSCC samples and pancreas samples
were included as biological negative controls. We used
295T. Füle et al. / Virology 348 (2006) 289–296biotinylated anti-mouse IgG as secondary antibody and
VectaStain ABC Kit (Vector) for signal amplification. Subse-
quently, we used biotinyl-tyramide at a 1:125 dilution for extra
amplification to increase sensitivity of immunostaining (Merz et
al., 1995). We have also performed a biotin-independent ampli-
fication procedure using anti-mouse IgG EnVision system
(DakoCytomation). This reagent is a dextran polymer conju-
gated with antibodies and peroxidase enzyme molecules.
Finally, 3,3-diaminobenzidine (DAB) was added as substrate-
chromogen for visualization.
The same ABC method was used for fluorescent detection,
but streptavidin-FITC was applied at the final step after bio-
tinyl-tyramide amplification. The nuclei were counterstained
with propidium-iodide or DAPI.
For the simultaneous identification of HPV E6 and Schwann
cells, anti-HPV 16, 18 E6 (see above), and polyclonal rabbit
anti-S100 (DakoCytomation) antibodies were used for double
immunostaining. HPV E6 was visualized in green with strep-
tavidin-FITC as described earlier; S100 was labeled red using
Alexa Fluor 568 goat anti-rabbit IgG antibody (Molecular
Probes, Eugene, OR, USA).
Laser microdissection
Nerves or blood vessels which proved to react with anti-E6
antibody, as well as the immunhistochemically E6-negative
nerves and vessels were dissected by laser pressure catapulting
technique with a laser microdissector (P.A.L.M. Microlaser
Technologies AG, Bernried, Germany). Special care was taken
to avoid contamination of nerves and blood vessels with tumor
tissue. Positive and negative control samples described above
(see ISH and IHC) were included. As additional negative
control, striated muscle tissue from the surroundings of tumor
was also excised to demonstrate that HPV positivity of nerves
and blood vessels is not a mere consequence of spatial proxi-
mity to the virus-containing tumor.
DNA isolation, polymerase chain reaction (PCR), and
sequencing
DNA coding for HPV 16 E6 early protein was detected in
unmounted formalin-fixed, paraffin-embedded sections and in
their selected fragments dissected by microlaser. For DNA
isolation, we used a PCR sample preparation kit (Roche
Diagnostics GmbH, Mannheim, Germany) according to the
suggested protocol.
Nested PCR amplification was carried out on 1 μl of DNA
extract (Nawa et al., 1993). In the first round, a pair of consensus
outer primers was used to amplify E6 ORF sequence of HPV
types 16, 18, and 33 (forward outer: 5′-ACCGAAAACGGTT-
GAACCGAAAACGGT-3′; reverse outer: 5′-AATAATGTC-
TATATTCACTAATT-3′). One-microliter aliquots of amplified
products from the first round were used as templates for the next
polymerase chain reaction. In this second round, primers exclu-
sively specific for HPV type 16 were applied (forward HPV type
16: 5′-ATGTTTCAGGACCCACAGGA-3′; reverse HPV type
16: 5′-CCTCACGTCGCAGTAACTGT-3′). DNA coding forL1 protein was detected by conventional one-step PCR method
using GP5+/GP6+ and MY9/MY11 primer pairs.
PCR products amplified from microdissected samples were
sequenced. Direct sequencing of purified amplicons from both
strands was carried out with ABI 310 Genetic Analyzer
(Applied Biosystems, Foster City, CA, USA), according to the
manufacturer's instructions. The obtained sequences were com-
pared to corresponding viral sequences available in the National
Center for Biotechnology Information (NCBI) GenBank
database.
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